In a 68‑year‑old woman with atrial fibrillation who presents 10 hours after acute right facial droop, right upper‑extremity weakness, and aphasia, NIH Stroke Scale 11, non‑contrast head CT without hemorrhage and CT angiography showing left middle cerebral artery M1 occlusion, which additional imaging study is most useful to determine candidacy for mechanical thrombectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Perfusion CT is the Most Useful Additional Test

For this 68-year-old woman presenting 10 hours after stroke onset with confirmed M1 occlusion, perfusion CT is the most useful additional test to determine mechanical thrombectomy candidacy, as it identifies salvageable penumbra versus irreversibly infarcted core in the extended time window. 1, 2, 3

Why Perfusion Imaging is Essential Beyond 6 Hours

  • CT perfusion becomes mandatory for patients presenting 6-24 hours after symptom onset to select candidates for endovascular therapy by demonstrating viable tissue that can be saved 2, 3
  • The major late-window thrombectomy trials (DAWN and DEFUSE-3) specifically required perfusion imaging (either CT perfusion or MRI diffusion/perfusion) to identify patients with small ischemic cores who would benefit from intervention 4
  • Perfusion CT differentiates between infarcted core and salvageable penumbra, which is the critical determination for treatment eligibility in the extended window 3
  • At 10 hours post-onset, this patient falls squarely into the extended window where tissue viability—not just vessel patency—determines treatment benefit 1, 2

Why Other Options Are Less Useful

Coagulation Studies (INR, PT, aPTT)

  • While coagulation parameters are important baseline labs, they should never delay imaging or treatment decisions 2
  • These tests are primarily relevant for IV thrombolysis contraindications, but this patient is already beyond the 4.5-hour tPA window 4
  • For mechanical thrombectomy, coagulation abnormalities are not absolute contraindications—the procedure can often proceed with appropriate precautions 4

Platelet Count

  • Platelet count is a routine safety parameter but does not determine thrombectomy candidacy 4
  • Thrombocytopenia below 100,000/μL would be a relative contraindication, but this does not help identify which patients will benefit from the procedure 4

FLAIR MRI or T1/T2-Weighted MRI

  • While MRI with diffusion-weighted imaging is superior to CT for detecting acute ischemia, it does not provide the critical perfusion mismatch information needed for extended-window decision-making 1, 3
  • FLAIR can identify stroke onset timing in wake-up strokes (FLAIR-negative/DWI-positive suggests <4.5 hours), but this patient has a known 10-hour onset 1
  • Standard anatomic MRI sequences show the infarct but not the salvageable penumbra 3

Practical Implementation

The recommended imaging protocol for this patient is:

  • Non-contrast CT head (already completed—shows no hemorrhage or obvious large infarct) 2
  • CT angiography (already completed—confirms M1 occlusion) 2
  • CT perfusion immediately to quantify ischemic core volume and penumbra 2, 3

Interpretation criteria for thrombectomy eligibility:

  • Small ischemic core volume (typically <70 mL on automated software) 4
  • Substantial penumbra (mismatch ratio typically >1.8) 4
  • Target mismatch profile indicating salvageable tissue despite the 10-hour delay 4, 3

Critical Pitfall to Avoid

  • Do not obtain perfusion imaging in obvious thrombectomy candidates within the first 6 hours, as this causes harmful treatment delays 2
  • However, at 10 hours post-onset, perfusion imaging is not optional—it is the evidence-based standard for patient selection 4, 2, 3

References

Guideline

Imaging Guidelines for Acute Ischemic Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acute Stroke Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Stroke Diagnosis and Imaging

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the management approach for a patient presenting with an M1 (Middle Cerebral Artery) stroke?
What is the recommended physical exam and management for a patient with a right M2 (middle cerebral artery) occlusion?
What is the management approach for post-infectious vasculopathy leading to Middle Cerebral Artery (MCA), M1 occlusion?
Should distal vessel occlusions in the M2, A1, or P1 segments be treated with thrombectomy?
What is the purpose of safeguarding flow stasis (prevention of blood flow cessation) post-thrombectomy in patients with acute ischemic stroke?
In a 16-year-old female with witnessed cardiac arrest who is receiving effective bag-mask ventilation with equal bilateral breath sounds, adequate chest rise, and good oxygen saturation, what is the best next step for the transport team: continue bag-mask ventilation, endotracheal intubation, nasopharyngeal airway placement, or oropharyngeal airway placement?
In a 45-year-old woman with a one‑month history of painless jaundice, weight loss, altered mental status, ascites, distended abdominal veins, anemia with low haptoglobin, normal reticulocyte count, low lactate dehydrogenase, and a cholestatic pattern (markedly elevated alkaline phosphatase and gamma‑glutamyltransferase, elevated direct bilirubin, modest transaminase elevations), what is the most likely diagnosis?
A 2‑year‑old girl with acute viral croup (barking cough, inspiratory stridor, retractions) – which is the most appropriate initial therapy: facemask helium‑oxygen, facemask humidified oxygen, nebulized albuterol, or nebulized racemic epinephrine?
Can subcutaneous hormone pellets (testosterone or estrogen) be safely removed?
What is the treatment for cerebrospinal fluid‑venous (CSF‑venous) fistulas?
In a 68-year-old man two weeks after tracheostomy who presents with bright‑red bleeding from the tracheostomy tube inner cannula and stable vital signs, what is the most appropriate first‑line intervention to control the bleeding?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.